You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ElevatION:CRC-102

Showing 1 - 25 of 805
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Guangzhou (fruquintinib plus TAS-102)

Recruiting
  • Metastatic Colorectal Cancer
  • fruquintinib plus TAS-102
  • Guangzhou, Guangdong, China
    the first affiliated hospital of Sun Yat-sen University
Aug 17, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Colorectal Carcinoma Trial in Rochester

Recruiting
  • Metastatic Colon Adenocarcinoma
  • +10 more
  • Colorectal Cancer Peptide Vaccine PolyPEPI1018
  • Trifluridine and Tipiracil Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 10, 2022

Refractory Metastatic Colorectal Cancer Trial in Denver, Sarasota, Nashville (TAS-102, nivolumab)

Completed
Has Results
  • Refractory Metastatic Colorectal Cancer
  • Denver, Colorado
  • +2 more
Jul 2, 2021

Colorectal Cancer, Colorectal Carcinoma, Metastatic Cancer Trial in Orange (Cabozantinib, TAS-102)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Sep 30, 2021

Refractory Colorectal Carcinoma, Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8 Trial in Houston

Recruiting
  • Refractory Colorectal Carcinoma
  • +8 more
  • Best Practice
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 24, 2021

Metastatic Colorectal Cancer Trial in Sutton (PDR001, bevacizumab, mFOLFOX6)

Terminated
  • Metastatic Colorectal Cancer
  • Sutton, Surrey, United Kingdom
    Novartis Investigative Site
Oct 7, 2021

Neovascular Age-Related Macular Degeneration Trial in United States (Drug: GB-102, Aflibercept)

Completed
Has Results
  • Neovascular Age-Related Macular Degeneration
  • Gilbert, Arizona
  • +32 more
Jan 10, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

Fruquintinib in the Cross-line Treatment of Refractory mCRC

Recruiting
  • Fruquintinib
  • Metastatic Colorectal Cancer
  • Wuhan, Hubei, China
  • +2 more
Oct 23, 2023

Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in United States (MB-102, Fludarabine, Cyclophosphamide)

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • MB-102
  • +2 more
  • Duarte, California
  • +3 more
Jul 12, 2022

Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Bevacizumab combined with Oxaliplatin and TAS-102
  • (no location specified)
May 16, 2022

Metastatic Colorectal Cancer Trial in Worldwide (spartalizumab (PDR001), regorafenib)

Completed
  • Metastatic Colorectal Cancer
  • St Leonards, New South Wales, Australia
  • +10 more
Dec 9, 2020

Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • (no location specified)
Jul 27, 2023

Diabetic Foot Infection Trial (TP-102, Placebo)

Not yet recruiting
  • Diabetic Foot Infection
  • TP-102
  • Placebo
  • (no location specified)
Jul 6, 2023

Trifluridine/Tipiracil Plus Bevacizumab Versus

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 11, 2023

Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Sep 8, 2023

Diabetic Gastroparesis Trial in United States (CIN-102 Dose 1, CIN-102 Dose 2, Placebo)

Recruiting
  • Diabetic Gastroparesis
  • CIN-102 Dose 1
  • +2 more
  • Tucson, Arizona
  • +19 more
Apr 14, 2023

Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,

Completed
  • Rectal Adenocarcinoma
  • +4 more
  • Quality-of-Life Assessment
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jan 3, 2023

Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

Active, not recruiting
Has Results
  • Cholangiocarcinoma
  • +6 more
  • Laboratory Biomarker Analysis
  • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
  • Scottsdale, Arizona
  • +1 more
Jan 4, 2023

Colon Cancer, Rectal Cancer Trial in United States (TAS-102, oxaliplatin, irinotecan with bevacizumab)

Not yet recruiting
  • Colon Cancer
  • Rectal Cancer
  • TAS-102, oxaliplatin, irinotecan with bevacizumab
  • Elizabeth, New Jersey
  • +6 more
Apr 7, 2023

Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of

Completed
Has Results
  • Conjunctivitis, Allergic
  • ADX-102 Ophthalmic Drops (0.5%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Dec 14, 2022

Kidney Diseases, Kidney Injury, Kidney Failure Trial in Suzhou, Xuzhou (MB-102 DMID, MB-102 OMID, MediBeacon Transdermal

Recruiting
  • Kidney Diseases
  • +2 more
  • MB-102 DMID
  • +2 more
  • Suzhou, Jiangsu, China
  • +1 more
Jul 11, 2023

Kidney Diseases, Kidney Injury, Kidney Failure Trial in Chicago, San Antonio (MB-102, MediBeacon Transdermal Glomerular

Recruiting
  • Kidney Diseases
  • +2 more
  • MB-102
  • MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR)
  • Chicago, Illinois
  • +1 more
Mar 22, 2023

Dry Eye Disease Trial in Rush (INV-102, Vehicle)

Recruiting
  • Dry Eye Disease
  • Rush, New York
    iuvo BioScience
Jan 12, 2023

Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Nanoliposomal Irinotecan
  • Trifluridine and Tipiracil Hydrochloride
  • Atlanta, Georgia
  • +2 more
Jan 6, 2023